CLBS
Price:
$0.4264
Market Cap:
$3.35M
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences...[Read more]
Industry
Biotechnology
IPO Date
1995-11-03
Stock Exchange
NASDAQ
Ticker
CLBS
According to Caladrius Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -91618632.00. This represents a change of -889.59% compared to the average of 11.60M of the last 4 quarters.
The mean historical Enterprise Value of Caladrius Biosciences, Inc. over the last ten years is -6337047.29. The current -91618632.00 Enterprise Value has changed 144.48% with respect to the historical average. Over the past ten years (40 quarters), CLBS's Enterprise Value was at its highest in in the June 2021 quarter at 83.32M. The Enterprise Value was at its lowest in in the December 2021 quarter at -44798857.60.
Average
-6337047.29
Median
3.79M
Minimum
-81975696.00
Maximum
24.19M
Discovering the peaks and valleys of Caladrius Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 876.74%
Maximum Annual Enterprise Value = 24.19M
Minimum Annual Increase = -1424.07%
Minimum Annual Enterprise Value = -81975696.00
Year | Enterprise Value | Change |
---|---|---|
2021 | -81975696.00 | -1424.07% |
2020 | 6.19M | -49.41% |
2019 | 12.24M | -49.42% |
2018 | 24.19M | 876.74% |
2017 | 2.48M | -76.67% |
2016 | 10.62M | 525.97% |
2015 | 1.70M | -66.75% |
2014 | 5.10M | -113.71% |
2013 | -37209262.59 | 455.39% |
2012 | -6699707.33 | -229.36% |
The current Enterprise Value of Caladrius Biosciences, Inc. (CLBS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-21182248.67
5-year avg
-7375179.49
10-year avg
-6337047.29
Caladrius Biosciences, Inc.’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Caladrius Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Caladrius Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Caladrius Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Caladrius Biosciences, Inc. (CLBS)?
What is the 3-year average Enterprise Value for Caladrius Biosciences, Inc. (CLBS)?
What is the 5-year average Enterprise Value for Caladrius Biosciences, Inc. (CLBS)?
How does the current Enterprise Value for Caladrius Biosciences, Inc. (CLBS) compare to its historical average?